BET bromodomain inhibitors (Eli Lilly/University of Minnesota)

N/A

Report date: 2025/03/14 20:00:48
NME

Base Information

Drug NameBET bromodomain inhibitors (Eli Lilly/University of Minnesota)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBromodomain and extra terminal domain protein inhibitorsBromodomain-containing protein 4 inhibitors
TargetsBromodomain and extra terminal domain proteinBromodomain-containing protein 4
Therapy Area/IndicationsInflammationHeart DiseasesInfertility, Male +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesEli Lilly And Company
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesUniversity Of MinnesotaEli Lilly And Company
Active IndicationsN/A
Inactive IndicationsInflammationHeart DiseasesInfertility, Male +[4] 

Other Information

ATC CodeN/A
Related LinksN/A